**Core Concept:** Increasing HDL cholesterol levels can have beneficial effects on cardiovascular health, as HDL (high-density lipoprotein) cholesterol is associated with a lower risk of coronary artery disease.

**Why the Correct Answer is Right:** Niacin (nicotinic acid) is an effective agent for raising HDL cholesterol levels. It works by inhibiting hepatic lipase, a key enzyme involved in the breakdown of HDL particles, reducing their degradation and increasing their number in the bloodstream.

**Why Each Wrong Option is Incorrect:**

A. Statins (e.g., atorvastatin, simvastatin) are primarily known for their cholesterol-lowering effects on LDL (low-density lipoprotein) cholesterol, not HDL.

B. Fibrates (e.g., bezafibrate, fenofibrate) primarily target triglyceride-lowering effects, not HDL cholesterol.

C. Niacin and fibrates are different compounds targeting different lipid parameters, while statins and HMG-CoA reductase inhibitors (e.g., simvastatin, atorvastatin) are lipid-lowering agents primarily targeting LDL cholesterol.

**Clinical Pearl:** It is essential to individualize lipid-lowering therapy based on patient risk factors and lipid profiles. Combining statins with fibrates or niacin may be considered for specific patients with elevated triglycerides and low HDL cholesterol levels, but these combinations should be carefully monitored for potential side effects and potential drug interactions.

**Correct Answer:** D. Niacin (nicotinic acid)

Niacin is the correct choice as it specifically targets HDL cholesterol levels, thereby improving overall cardiovascular health. Always consider discussing potential side effects (e.g., flushing, liver enzyme elevation) and monitoring lipid profiles carefully when using niacin as part of a comprehensive lipid-lowering regimen.